A health-policy analysis of the international Ozempic price gap, the complex role of insurers and pharmacy benefit managers, and the political debate over who is responsible for the high cost of prescription drugs in the United States.
Read more
AI
Drama
Journalism
Local
Public Affairs
Sports
Becht Works
DEC Productions
Der Tagesspiegel
Health Compass
Independent Productions
Kindle Direct Publishing
Lawton Constitution
Medium
Pforzheimer Zeitung
Rebellium Films
Articles
Books
Interviews
Movies
Videos